New JerseyRevises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jun 30Substituted by A4852 (ACS)Latest
- Jun 11Reported from Senate Committee as a Substitute, 2nd ReadingMinor
- Vote recorded Reported out of Senate committee as a substitute. Result: pass.Upper
- May 11Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens CommitteeIntroduced